StockNews.AI
CGC
StockNews.AI
14 days

Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia

1. Canopy Growth expands its 7ACRES brand into Australia with new strains. 2. Introduction of high-THC varieties may enhance revenue streams for CGC.

2m saved
Insight
Article

FAQ

Why Bullish?

Expanding into Australia diversifies CGC's market presence, historically strengthening stock performance in new markets.

How important is it?

The launch of new strains in Australia indicates growth potential, crucial for CGC's recovery trajectory.

Why Long Term?

Successful brand expansion could lead to sustained sales growth, similar to the U.S. market entry outcomes.

Related Companies

WEEDAPHACXXI
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the Company's medical cannabis offering with two high-THC sativa strains: Ultra Jack and Jack Frost. Ultra Jack, a cross of Ultra Sour and Jack Haze, is one of 7ACRES' top performing flower strains in th.

Related News